Secretion of Reelin by blood vessels affects the formation of the cerebral cortex

Lead Research Organisation: University College London
Department Name: Cell and Developmental Biology

Abstract

The developing forebrain is surrounded by blood vessels before the first neurons are generated. Vascular networks subsequently invade the embryonic forebrain as newly born neurons migrate to form the six layers that will comprise the adult cerebral cortex. While it was previously believed that blood vessels only have a supportive role during development, it is now widely accepted that they provide instructive signals to regulate the generation and migration of cortical neurons. More recently, defective blood vessel development has been suggested to contribute to cortical pathologies of neurodevelopmental origin. We have found that blood vessels secrete Reelin, a protein which has a crucial role in the formation and connectivity of the rodent and human cerebral cortex, and which has also been linked to neurodevelopmental disorders in humans. While Reelin has been detected in human and rodent blood plasma, little is known about its significance and function in the formation of the cerebral cortex. Here, we propose to use genetic strategies in mice to remove Reelin specifically from blood vessels and analyse how the formation of the cerebral cortex is affected. Further, we will use mouse models in a strategy aimed to shed light on the molecular mechanisms by which blood vessels secrete Reelin and communicate with neurons in the developing brain. Thus, the proposed research programme will explore novel mechanisms that underlie the secretion of a key molecule, Reelin, by blood vessels and the communication between vasculature and neurons during the formation of the cerebral cortex. This work is likely to enhance our understanding of the aetiologies of developmental disorders of this area of the brain such as schizophrenia and autism.

Technical Summary

Reelin is a secreted extracellular matrix protein which is known to play a crucial role in neuronal migration, layer formation and connectivity in the developing cerebral cortex. Reeler mouse mutants show severe defects in cortical lamination and synapse formation which underlie their marked motor deficits. While it was previously thought that Cajal-Retzius cells and some interneurons are the sole sources of this protein in the developing cortex, a recent study has suggested that cortical blood vessels express Reelin and its receptors. This is consistent with the detection of Reelin in rodent and human blood serum and with the finding of elevated levels in the plasma of patients with neuropsychiatric disorders. However, the function of circulating Reelin in the formation of the cortex remains unknown. Prompted by preliminary data which showed secretion by cortical endothelial cells, we propose to investigate the function of vascular-Reelin in corticogenesis by using a genetic ablation strategy to specifically remove this protein from endothelial cells in vivo. Moreover, we have recently found that blood vessels are enriched in members of the family of SNARE proteins, including Snap25 which mediates regulated exocytosis in neurons. We propose to use a genetic conditional Cre-Lox strategy to test whether Snap25 mediates vascular-exocytosis and whether Reelin is released by this process. Other candidate SNARE members which are enriched in blood vessels and which may underlie Reelin secretion will be identified by RNA sequencing experiments, and candidates tested by knocking down specific SNARE members in vascular endothelial cells in vitro using siRNA. These experiments will be combined with biochemical studies with the aim to identify the molecular partners underlying Reelin secretion and, more generally, neurovascular coupling. Thus, the proposed studies will elucidate how blood vessels communicate with neurons to regulate the formation of the cerebral cortex.

Planned Impact

Firstly, success of this application will have a positive impact on our laboratory which has provided a fertile ground for training of students, postdoctoral fellows and visiting scientists from around the world for the past three decades. Most of them have since gone to become independent and productive scientists. This grant, if successful, will allow us to investigate the novel hypothesis that aberrant secretion of Reelin from blood vessels in the developing brain affects its formation and may contribute to the aetiology of neurodevelopmental disorders. The wide range of techniques included in the project comprise highly transferable skills for people in the laboratory to use in other projects here or other institutions in the future.

The proposed programme of research aims to investigate the complex mechanisms by which blood vessels communicate with neurons in the brain through the secretion of a repertoire of molecules including Reelin. This line of work complements our present and past interests, and those of other groups worldwide, on the cell and molecular mechanisms involved in the formation of the brain, especially of the cerebral cortex. Although I expect the short-term benefit of this research to be academic, a long-term positive effect on public health and economy is likely as it will increase the understanding of mechanisms that may underlie neuropsychiatric disorders of developmental origin, especially of schizophrenia. Understanding such mechanisms may contribute to therapeutic approaches for these disorders. In addition to disseminating our experimental findings to the basic science and medical communities, I will also strive to include our research as part of my undergraduate and postgraduate teaching.

Publications

10 25 50
 
Description We previously observed that Reelin, an extracellular matrix protein typically associated with neurons, and which is an essential regulator of cortical lamination during development, and of synaptic plasticity and function in the adult, was also expressed within vascular endothelial cells which form blood vessels. Our objective was to investigate vascular-Reln during cortical development. We examined Reln secretion in VECs and found that its N-terminal isoforms were secreted by a vascular endothelial GPNT cell line in-vitro. Interestingly, while inhibiting the constitutive secretion of Reln pharmacologically with Brefeldin did not yield conclusive results, we found that blocking VegfR1-3 with Axitinib, resulted in the increased secretion of Reln from GPNT cells, likely due to its action through the recently identified non-canonical Reln receptor VegfR2. In addition, as has been shown previously for neurons, Reln colocalised with the endosomal recycling protein Rab11a in VECs and inhibiting endosomal trafficking without impairing endocytosis with Bafilomycin treatments, resulted in the redistribution of Reln from the somal cytoplasm and elongated processes to perinuclear locations; with a reduction in the motility of Reln-Gfp tagged proteins also observed in live-imaging studies. Together, these studies suggested that vascular-Reln is trafficked via an endosomal pathway and secreted in vitro. We next generated a floxed Reln transgenic mouse line to specifically deplete Reelin from endothelial cells together with mice in which Reelin is depleted ubiquitously. We find that the global depletion of Reln recapitulated the ataxic gait, hypoplastic and dysfoliated cerebellum, and dyslaminated cerebral cortex, hippocampus and cerebellum previously described in Reeler mutants. In addition, we found a severe perturbation of cortical interneuron distribution and positioning. While we were unable to generate Tie2+ endothelial-cell mutants for unknown reasons, we find that depleting vascular-Reln from a single allele, when in a Reeler heterozygous background results in severe haemorraghing and the necrosis of embryonic forebrain tissue. In addition, we report a striking altered density but increased activation of microglia throughout the Reelin-deficient postnatal mouse forebrain. While the ubiquitous increased activation of microglia may be due to the recently reported defective BBB in these mutants, we find that microglia express Reelin, and canonical and non canonical Reln receptors, raising the interesting possibility that Reln signalling may play a role in microglial process morphogenesis, activation and function. This identifies for the first time the involvement of Reln signalling in microglia, and is work currently in preparation for submission by MB, now based at KCL. Microglia have been shown to directly regulate neuronal numbers through their phagocytosis of intermediate progenitors and to dynamically remodel axonal tracts and synapses to establish neural circuits during development, and thus an understanding of how Reelin signalling influences microglial activation and function is not only mechanistically interesting, but could also be pertinent to neurodevelopmental disorders such as schizophrenia and autism, in which Reelin levels in the forebrain are altered. Work from this project is currently in preparation for submission.
Exploitation Route The findings are of interest to scientists interested in cortical development in mammals and also shed light on novel mechanisms by which non-neuronal sources of Reelin could be implicated in neurodevelopmental disorders in which Reln levels are altered. Our observations that the brain-resident immune microglial cells are influenced by Reln signalling could provide a new mechanism by which microglia influence neurogenesis and promote neural circuit formation during brain development, but also could be a mechanism compounding synaptic dysfunction in neurodegenerative disease such as Alzheimer's in which Reln levels are downregulated and hyper-activation of microglia have been reported.
Sectors Pharmaceuticals and Medical Biotechnology